US Patent Issued to TRANSLATE BIO on Aug. 11 for "Treatment of cystic fibrosis by delivery of codon-optimized mRNA encoding CFTR" (Massachusetts Inventors)

ALEXANDRIA, Va., Aug. 12 -- United States Patent no. 12,702,693, issued on Aug. 11, was assigned to TRANSLATE BIO INC. (Waltham, Mass.).

"Treatment of cystic fibrosis by delivery of codon-optimized mRNA encoding CFTR" was invented by Michael Heartlein (Lexington, Mass.), Frank DeRosa (Lexington, Mass.), Alan Kimura (Lexington, Mass.), Jonathan Abysalh (Lexington, Mass.), Anusha Dias (Lexington, Mass.), Shrirang Karve (Lexington, Mass.) and Zarna Patel (Lexington, Mass.).

According to the abstract* released by the U.S. Patent & Trademark Office: "The present invention provides, among other things, methods of treating cystic fibrosis, comprising a step of administering to a subject in need of treatment a composition comprising an mRNA encod...